N-(4-(N-(3-((3,5-Dimethoxyphenyl)amino)quinoxalin-2-yl)sulfamoyl)phenyl)-3-methoxy-4-methylbenzamide

CAS : 1349796-36-6

Ref. 3D-FD138858

Informations sur le produit

• Nom: N-(4-(N-(3-((3,5-Dimethoxyphenyl)amino)quinoxalin-2-yl)sulfamoyl)phenyl)-3-methoxy-4-methylbenzamide
• Synonymes: Benzamide, N-[4-[[[3-[(3,5-dimethoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-3-methoxy-4-methyl-, Xl765, Xl-765, Sar245409, Voxtalisib

Description

N-(4-(N-(3-((3,5-Dimethoxyphenyl)amino)quinoxalin-2-yl)sulfamoyl)phenyl)-3-methoxy-4-methylbenzamide is a replication inhibitor that binds to the receptor Toll-like and blocks the activation of macrophages. This drug has been shown to have a cytostatic effect on tumor cells in vitro, which may be due to its ability to inhibit epidermal growth factor (EGF). N-(4-(N-(3-((3,5-Dimethoxyphenyl)amino)quinoxalin-2-yl)sulfamoyl)phenyl)-3-methoxy-4-methylbenzamide has also been shown to have proapoptotic effects on immune cells such as natural killer cells. This drug inhibits the growth of solid tumours by inhibiting cell signaling pathways and interfering with the

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 599.66 g/mol
• Formule: C₃₁H₂₉N₅O₆S
• Degré de pureté: Min. 95%